673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

Ítems similars

• SYN-007, an Orally Administered Beta-Lactamase Enzyme, Protects the Gut Microbiome from Oral Amoxicillin/Clavulanate without Adversely Affecting Antibiotic Systemic Absorption in Dogs
  per: Connelly, Sheila, et al.
  Publicat: (2020)
• Oral Beta-Lactamase Protects the Canine Gut Microbiome from Oral Amoxicillin-Mediated Damage
  per: Connelly, Sheila, et al.
  Publicat: (2019)
• 620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis
  per: Connelly, Sheila, et al.
  Publicat: (2018)
• Low dose oral beta-lactamase protects the gut microbiome from oral beta-lactam-mediated damage in dogs
  per: Connelly, Sheila, et al.
  Publicat: (2019)
• Oral Metallo-Beta-Lactamase Protects the Gut Microbiome From Carbapenem-Mediated Damage and Reduces Propagation of Antibiotic Resistance in Pigs
  per: Connelly, Sheila, et al.
  Publicat: (2019)